Contact Us

All Categories

Refine Search

SR31527

Novel inhibitor of kinesin-like protein KIFC1

SR9011 Hydrochloride

Novel agonist of Rev-ErbAalpha/beta

SR9238

The first selective synthetic LXR inverse agonist

SR9243

Novel LXR inverse agonist

Src-I1

Potent, competitve dual site (both the ATP- and peptide-binding) Src kinase inhibitor

SRI-011381

Novel agonist of the TGF-beta signaling pathway for treatment of Alzheimer's disease

SRI-31215 Bis-TFA Salt

Novel triplex inhibitor of matriptase, hepsin and HGFA, mimicing the activity of HAI-1/2, endogenousing inhibitors of HGF activation

SRPIN340

Novel SR protein phosphorylation inhibitor

SRT-1720

A selective SIRT1 activator with EC50 of 0.16 μM in a cell-free assay, but is >230-fold less potent for SIRT2 and SIRT3.

SSAA09E1

A novel inhibitor of SARS-CoV replication, acting by blocking cathepsin L, a host protease required for processing of SARS-S during viral entry

Ssioriside

Lignans

SSR128129E

A multi-FGFR inhibitor, SSR128129E inhibits responses mediated by FGFR1-4 and thus results in the blockage of proliferation and/or migration in various cell lines including mPanc02, HEK-hFGFR2WT, PAE-hFGFR1, hB9-myeloma and HUVEC